Pure Biologics S.A. (WSE:PUR)
3.584
-0.016 (-0.44%)
At close: Feb 12, 2026
-76.11% (1Y)
| Market Cap | 44.08M -29.3% |
| Revenue (ttm) | n/a |
| Net Income | -17.93M |
| EPS | -4.52 |
| Shares Out | 12.24M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 35,215 |
| Average Volume | 215,122 |
| Open | 3.642 |
| Previous Close | 3.600 |
| Day's Range | 3.580 - 3.678 |
| 52-Week Range | 3.100 - 17.100 |
| Beta | 0.70 |
| RSI | 42.02 |
| Earnings Date | Apr 30, 2026 |